QUIDELORTHO CORP Other Comprehensive Income (Loss), Net of Tax
QUIDELORTHO CORP (QDEL) reported Other Comprehensive Income (Loss), Net of Tax of -$35.90 million for the 3-month period ending 2025-09-28, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2025-11-06
- QUIDELORTHO CORP other comprehensive income (loss), net of tax for the quarter ending 2025-09-28 was -$35.90M, a 270.14% decline year-over-year.
- QUIDELORTHO CORP other comprehensive income (loss), net of tax for the quarter ending 2025-06-29 was $40.00M, a 2400.00% increase year-over-year.
- QUIDELORTHO CORP other comprehensive income (loss), net of tax for the quarter ending 2025-03-30 was $12.40M, a 226.32% increase year-over-year.
- QUIDELORTHO CORP other comprehensive income (loss), net of tax for the quarter ending 2024-09-29 was $21.10M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month |
|---|---|---|---|
| 2025-09-28 | -$35.90M 10-Q · filed 2025-11-06 | $4.10M derived: sum of 2 quarters · filed 2025-11-06 | $16.50M derived: sum of 3 quarters · filed 2025-11-06 |
| 2025-06-29 | $40.00M 10-Q · filed 2025-11-06 | $52.40M derived: sum of 2 quarters · filed 2025-11-06 | |
| 2025-03-30 | $12.40M 10-Q · filed 2025-11-06 | ||
| 2024-09-29 | $21.10M 10-Q · filed 2025-11-06 | $22.70M derived: sum of 2 quarters · filed 2025-11-06 | $26.50M derived: sum of 3 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.60M 10-Q · filed 2025-11-06 | $5.40M derived: sum of 2 quarters · filed 2025-11-06 | |
| 2024-03-31 | $3.80M 10-Q · filed 2025-11-06 | ||
| 2023-10-01 | -$36.90M 10-Q · filed 2024-11-08 | $6.10M derived: sum of 2 quarters · filed 2024-11-08 | $14.40M derived: sum of 3 quarters · filed 2024-11-08 |
| 2023-07-02 | $43.00M 10-Q · filed 2024-11-08 | $51.30M derived: sum of 2 quarters · filed 2024-11-08 | |
| 2023-04-02 | $8.30M 10-Q · filed 2024-11-08 | ||
| 2022-10-02 | -$83.80M 10-Q · filed 2023-11-02 | -$144.70M derived: sum of 2 quarters · filed 2023-11-02 | -$144.90M derived: sum of 3 quarters · filed 2023-11-02 |
| 2022-07-03 | -$60.90M 10-Q · filed 2023-11-02 | -$61.10M derived: sum of 2 quarters · filed 2023-11-02 | |
| 2022-04-03 | -$200.00K 10-Q · filed 2023-11-02 | ||
| 2021-10-03 | -$200.00K 10-Q · filed 2022-11-04 | $700.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.20M derived: sum of 3 quarters · filed 2022-11-04 |
| 2021-07-04 | $900.00K 10-Q · filed 2022-11-04 | $1.40M derived: sum of 2 quarters · filed 2022-11-04 | |
| 2021-04-04 | $500.00K 10-Q · filed 2022-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |